Duloxetine Capsule, Delayed Release
Product Images NDC 52427-791

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Duloxetine (NDC 52427-791). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Almatica Pharma Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image
Brand-logo (Brand Logo)
This is a description of Duloxetine Delayed-Release Capsules available in three strengths: 80mg, 90mg, and 120mg. These capsules are likely used to treat various conditions such as depression, anxiety, and chronic pain.*
FDA Label Image

Figure1 (Figure 1)

Figure1 (Figure 1)
This text presents data related to the number of patients experiencing a relapse over time between two treatment groups - Placebo and Duloxetine. The graph displays the time from randomization to relapse in days, with data points at 100, 150, 200, and 250 days. It seems to be a clinical study chart comparing the effectiveness of Placebo and Duloxetine in preventing relapse in patients.*
FDA Label Image

Figure2 (Figure 2)

Figure2 (Figure 2)
This text shows a graph comparing the proportion of patients with relapse over time in a study comparing a placebo treatment to a treatment with duloxetine. The x-axis shows the time from randomization to relapse in days, while the y-axis shows the proportion of patients experiencing a relapse. The data indicates that fewer patients on duloxetine experienced relapse compared to those on placebo, supporting the effectiveness of duloxetine in preventing relapse.*
FDA Label Image

Label-120mg (Label 120mg)

Label-120mg (Label 120mg)
This is a description for a medication called Duloxetine, which is provided in the form of Delayed-Release Capsules. Each capsule contains 134.7 mg of duloxetine hydrochloride, which is equivalent to 120 mg of duloxetine. The recommended dosage should be obtained from the Prescribing Information. The medication should be stored at a temperature range of 20°C to 25°C (66°F to 77°F), with excursions permitted between 15°C to 30°C (59°F to 86°F). It is advised not to use the medication if the inner seal is missing or broken and to keep it out of reach of children. The medication is distributed by Almatica Pharma LLC in Morristown, N 07960, USA.*
FDA Label Image

Label-80mg (Label 80mg)

Label-80mg (Label 80mg)
Description: This text provides information on a medication called Duloxetine in the form of delayed-release capsules with a strength of 80 mg. It includes details on the active ingredient, recommended dosage, storage instructions, and a note to dispense the Medication Guide to each patient. The text also mentions the distributor as Almatica Pharma LLC based in Morristown, NJ, USA.*
FDA Label Image

Label-90mg (Label 90mg)

Label-90mg (Label 90mg)
This is a prescription medication called Duloxetine in the form of delayed-release capsules. Each capsule contains 101 mg of duloxetine hydrochloride, which is equivalent to 90 mg of duloxetine. The recommended dosage can be found in the prescribing information. It is advised to store the medication within a temperature range of 20°C to 25°C (68°F to 77°F) with excursions permitted from 15°C to 30°C (59°F to 86°F). It is important not to use if the inner seal is missing or broken and to keep it out of reach of children. This medication is distributed by Almatica Pharma LLC in Morristown, NJ.*
FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.